MedWatch

Ambu gets EU approval for bronchoscope

The Danish medtech company can now market its newest bronchoscope in Europe.

Photo: Ambu / PR

The EU has approved Ambu's latest bronchoscope and accompanying sample collector, the Ambu Ascope 4 Broncho Sampler Set. It has received the CE-mark authorization from the authority.

The news, which Ambu revealed on Wednesday, means that the company can now market this combined product in both Europe and the US, as Ambu has had the necessary US approvals in place since June.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs